ERLEADA ® is a prescription medicine used to treat two types of prostate cancer:
Prostate cancer that HAS SPREAD to other parts of the body and STILL responds to a medical or surgical treatment that lowers testosterone.
This is called metastatic castration-sensitive prostate cancer, or mCSPC.
OR
Prostate cancer that HAS NOT SPREAD to other parts of the body and NO LONGER responds to a medical or surgical treatment that lowers testosterone.
This is called non-metastatic castration-resistant prostate cancer, or nmCRPC.
How may ERLEADA ® help you?
The short quiz below can help you find specific information about prostate cancer and ERLEADA ® .
Please select the options that best describe your interest:
